Asian Phytoceuticals PCLBKK:APCO-R 62 EV-to-EBIT is 14.82 as of Jul. 04, 2026, which is 43% below its 10-year median of 25.95. GuruFocus rates BKK:APCO-R with a GF Score™ of 62/100 and a GF Value™ of ฿7.61. The stock has 4 warning signs investors should review. Among 1,553 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks worse than 63.49% on this metric.
The historical rank and industry rank for Asian Phytoceuticals PCL's EV-to-EBIT or its related term are showing as below:
BKK:APCO-R'
s EV-to-EBIT Range Over the Past 10 Years
Min: 13.83 Med: 25.95 Max: 55.27
Current: 14.82
During the past 13 years, the highest EV-to-EBIT of Asian Phytoceuticals PCL was 55.27. The lowest was 13.83. And the median was 25.95.
BKK:APCO-R's EV-to-EBIT is ranked worse than 63.49% of 1553
companies
in the Consumer Packaged Goods industry
Industry Median: 12.05
vs BKK:APCO-R: 14.82
Asian Phytoceuticals PCL (BKK:APCO-R) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Asian Phytoceuticals PCL's Enterprise Value for the quarter that ended in Mar. 2026 was ฿3,392.3 Mil.
Asian Phytoceuticals PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿77.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL EV-to-EBIT Related Terms
Asian Phytoceuticals PCL EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's EV-to-EBIT falls into.
Asian Phytoceuticals PCL's current Enterprise Value is ฿1,151.9 Mil.
Asian Phytoceuticals PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿77.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL (BKK:APCO-R) has a EV-to-EBIT of 14.82 as of Jul. 04, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Asian Phytoceuticals PCL and its competitors. This is 43% below median its historical median of 25.95. Over the past decade, Asian Phytoceuticals PCL's EV-to-EBIT has ranged from 13.83 to 55.27. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #986 out of 1553 companies in the Consumer Packaged Goods industry, placing it in the top 63.5%.
Is Asian Phytoceuticals PCL's EV-to-EBIT too high?
Asian Phytoceuticals PCL's current EV-to-EBIT of 14.82 is 43% below median its 10-year median of 25.95. Over the past 10 years, this metric has ranged from a low of 13.83 to a high of 55.27. The Consumer Packaged Goods industry median EV-to-EBIT is 12.05. Asian Phytoceuticals PCL's value of 14.82 is 23% above this industry median. Based on the distribution chart, Asian Phytoceuticals PCL ranks #986 out of 1553 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's EV-to-EBIT compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #986 out of 1553 companies for EV-to-EBIT. This places Asian Phytoceuticals PCL in the lower half of its industry. The industry median EV-to-EBIT is 12.05. Asian Phytoceuticals PCL's value of 14.82 is 23% above this benchmark. Historically, Asian Phytoceuticals PCL's own EV-to-EBIT has ranged from 13.83 to 55.27 over the past decade. While the company's 10-year median is 25.95 vs. the industry median of 12.05, Asian Phytoceuticals PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.05, based on 1,553 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asian Phytoceuticals PCL's current EV-to-EBIT of 14.82 is 23% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current EV-to-EBIT is 14.82, which is 43% below median its own 10-year median of 25.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current EV-to-EBIT of 14.82. The stock's GF Value™ is ฿7.61, compared to a current price of ฿6.27 — trading 17.6% below its estimated fair value. The current EV-to-EBIT is 14.82, which is 43% below median its 10-year median of 25.95 and 23% above the Consumer Packaged Goods industry median of 12.05. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current EV-to-EBIT is 14.82 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 17.6% below its estimated GF Value™ of ฿7.61.
Key valuation signals for BKK:APCO-R:
EV-to-EBIT: 14.82 (43% below median its 10-year median of 25.95)
GF Value™: ฿7.61 vs. price of ฿6.27 (17.6% below fair value)
Industry Position: 23% above the Consumer Packaged Goods median (#986 of 1553)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
